Screener
Organogenesis Holdings Inc. ORGO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Organogenesis Holdings Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
FAQ
- What is Organogenesis Holdings Inc.'s return on equity?
- Organogenesis Holdings Inc. (ORGO) reported return on equity of -44.1% in Q2 2026.
- How has Organogenesis Holdings Inc.'s return on equity changed year-over-year?
- Organogenesis Holdings Inc.'s return on equity decreased by 1231.2% year-over-year, from -3.3% to -44.1%.
- What is the long-term trend for Organogenesis Holdings Inc.'s return on equity?
- Over 4 years (2020 to 2025), Organogenesis Holdings Inc.'s return on equity has grown at a -7.7% compound annual growth rate (CAGR), from 18.2% to 13.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Organogenesis Holdings Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude